VestGen Advisors’s Boston Scientific BSX Stock Holding History

VestGen Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$580K	Buy	13,598 +3,716	+38%	+$202K	0.02%	619
2026 Q1	$535K	Sell	9,882 -887	-8%	-$71K	0.01%	645
2025 Q4	$1.03M	Sell	10,769 -5,905	-35%	-$579K	0.04%	356
2025 Q3	$1.63M	Sell	16,674 -1,300	-7%	-$135K	0.05%	282
2025 Q2	$1.93M	Buy	17,974 +9,656	+116%	+$977K	0.08%	220
2025 Q1	$839K	Buy	+8,318	New	+$838K	0.04%	324

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VestGen Advisors's BSX Position: Q2 2026 in Review

VestGen Advisors increased its Boston Scientific (BSX) stake by 38% in Q2 2026, buying an estimated $202K and bringing the position to 13,598 shares worth $580K. The position accounts for 0.02% of the portfolio, ranked #619.

VestGen Advisors first reported a position in BSX in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.93M in Q2 2025. 1,482 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

VestGen Advisors held 13,598 shares of Boston Scientific worth $580K as of Q2 2026.
VestGen Advisors bought 3,716 Boston Scientific shares in Q2 2026, an estimated $202K.
Boston Scientific made up 0.02% of VestGen Advisors's portfolio in Q2 2026, its #619 holding.
VestGen Advisors first reported a position in Boston Scientific in Q1 2025 and has held it in 6 quarters since.
VestGen Advisors's Boston Scientific position peaked at $1.93M in Q2 2025.
1,482 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on VestGen Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.